Most recently, it has been discovered that conolidine and the above mentioned derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in similar areas as classical opioid receptors, it binds to the big selection of endogenous opioids. Not like most opioid receptors, this receptor acts for a scavenger and does not activate a 2nd m